{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:25:50Z","timestamp":1756383950236},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"903","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,1,1]]},"DOI":"10.1136\/pmj.77.903.29","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:35:11Z","timestamp":1027766111000},"page":"29-32","source":"Crossref","is-referenced-by-count":5,"title":["Subclinical thyrotoxicosis"],"prefix":"10.1093","volume":"77","author":[{"given":"A C","family":"Al-Abadi","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Clinical Sciences Centre, Northern General Hospital , Herries Road, Sheffield S5 7AU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,1,1]]},"reference":[{"key":"2023042418250349300_B1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jcem-70-2-453","article-title":"Application of a new chemiluminometric thyrotropin assay to subnormal measurement.","volume":"70","author":"Spencer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B2","first-page":"494","article-title":"Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays.","volume":"76","author":"Spencer","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B3","first-page":"182","article-title":"Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.","volume":"40","author":"De Rosa","year":"1996","journal-title":"Q J Nucl Med"},{"key":"2023042418250349300_B4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2265.1999.00632.x","article-title":"Comparison of serum thyrotrophin concentrations determined by a third generation assay in patients with various types of overt and subclinical thyrotoxicosis.","volume":"50","author":"Kasagi","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023042418250349300_B5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1042\/bj0670005","article-title":"The metabolism of thyroid hormones. 2. Detection of thyroxine and triiodothyronine in human plasma.","volume":"67","author":"Maclagan","year":"1957","journal-title":"Biochem J"},{"key":"2023042418250349300_B6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0002-9343(90)90435-G","article-title":"Free triiodothyronine toxicosis: a distinct entity.","volume":"88","author":"Bitton","year":"1990","journal-title":"Am J Med"},{"key":"2023042418250349300_B7","first-page":"1160","article-title":"Asian women are at increased risk of gestational thyrotoxicosis.","volume":"81","author":"Price","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B8","first-page":"93","article-title":"Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.","volume":"45","author":"De Whalley","year":"1995","journal-title":"Br J Gen Pract"},{"key":"2023042418250349300_B9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0002-9343(94)90147-3","article-title":"The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis.","volume":"96","author":"Figge","year":"1994","journal-title":"Am J Med"},{"key":"2023042418250349300_B10","first-page":"1189","article-title":"The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine.","volume":"74","author":"Davies","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B11","first-page":"623","article-title":"Thyrotropin results in euthyroid patients with a past history of hyperthyroidism.","volume":"122","author":"Brownlie","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2023042418250349300_B12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/thy.1996.6.391","article-title":"The many causes of subclinical hyperthyroidism.","volume":"6","author":"Charkes","year":"1996","journal-title":"Thyroid"},{"key":"2023042418250349300_B13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jcem-70-1-89","article-title":"Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities.","volume":"70","author":"Salvi","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/eje.0.1360277","article-title":"Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.","volume":"136","author":"F\u00f6ldes","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2023042418250349300_B15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2265.1993.tb01752.x","article-title":"Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.","volume":"39","author":"Rieu","year":"1993","journal-title":"Clin Endocrinol"},{"key":"2023042418250349300_B16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1136\/bmj.297.6663.1586","article-title":"Screening for thyroid disease in a primary care unit with a thyroid-stimulating hormone assay with a low detection limit.","volume":"297","author":"Eggertsen","year":"1988","journal-title":"BMJ"},{"key":"2023042418250349300_B17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archinte.1990.00390160053012","article-title":"Thyroid dysfunction in adults over age 55 years. A study in an urban US community.","volume":"150","author":"Bagchi","year":"1990","journal-title":"Arch Intern Med"},{"key":"2023042418250349300_B18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2265.1991.tb01739.x","article-title":"Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom.","volume":"34","author":"Parle","year":"1991","journal-title":"Clin Endocrinol"},{"key":"2023042418250349300_B19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey.","volume":"43","author":"Vanderpump","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023042418250349300_B20","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1001\/archinte.1996.00440190083009","article-title":"Sensitive thyrotropin and free thyroxine testing in outpatients: are both necessary?","volume":"156","author":"Bauer","year":"1996","journal-title":"Arch Intern Med"},{"key":"2023042418250349300_B21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/pgmj.66.773.186","article-title":"The natural history of euthyroid multinodular goitre.","volume":"66","author":"Elte","year":"1990","journal-title":"Postgrad Med J"},{"key":"2023042418250349300_B22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF03346900","article-title":"Subclinical Graves\u2019 disease as a cause of subnormal TSH levels in euthyroid subjects.","volume":"20","author":"Kasagi","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"2023042418250349300_B23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/thy.1998.8.83","article-title":"Iodine-induced hyperthyroidism: occurrence and epidemiology.","volume":"8","author":"Stanbury","year":"1998","journal-title":"Thyroid"},{"key":"2023042418250349300_B24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03345479","article-title":"High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.","volume":"22","author":"Mariotti","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"2023042418250349300_B25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJM199207093270206","article-title":"Thyrotoxicosis and the heart.","volume":"327","author":"Woeber","year":"1992","journal-title":"N Engl J Med"},{"key":"2023042418250349300_B26","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"2023042418250349300_B27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"2023042418250349300_B28","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/archinte.1996.00440180083010","article-title":"How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators.","volume":"156","author":"Krahn","year":"1996","journal-title":"Arch Intern Med"},{"key":"2023042418250349300_B29","first-page":"2222","article-title":"Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of \u03b2-blockade.","volume":"80","author":"Fazio","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B30","first-page":"2592","article-title":"Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine.","volume":"82","author":"Shapiro","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B31","first-page":"334","article-title":"Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.","volume":"77","author":"Biondi","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1210\/jcem-70-3-766","article-title":"Negative correlation between the changes in bone mineral density and serum osteocalcin in patients with hyperthyroidism.","volume":"70","author":"Lee","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B33","first-page":"737","article-title":"Mineral and bone metabolism in thyroid disease: a review.","volume":"232","author":"Anwerx","year":"1986","journal-title":"Q J Med"},{"key":"2023042418250349300_B34","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1210\/jcem-72-6-1184","article-title":"A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma.","volume":"72","author":"Diamond","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1530\/eje.0.1300350","article-title":"Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.","volume":"130","author":"Faber","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"2023042418250349300_B36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF03346838","article-title":"Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH.","volume":"14","author":"Gam","year":"1991","journal-title":"J Endocrinol Invest"},{"key":"2023042418250349300_B37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0140-6736(92)92423-D","article-title":"Long-term thyroxine treatment and bone mineral density.","volume":"340","author":"Franklyn","year":"1992","journal-title":"Lancet"},{"key":"2023042418250349300_B38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9343(91)90066-7","article-title":"Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy.","volume":"91","author":"Greenspan","year":"1991","journal-title":"Am J Med"},{"key":"2023042418250349300_B39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2265.1992.tb01480.x","article-title":"Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH.","volume":"37","author":"Leese","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023042418250349300_B40","first-page":"1118","article-title":"Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid replacement.","volume":"82","author":"Al-Adsani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2265.1992.tb02351.x","article-title":"Circulating lipids and minor abnormalities of thyroid function.","volume":"37","author":"Parle","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023042418250349300_B42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.1999.9.273","article-title":"Variations of sex hormone-binding globulin in thyroid dysfunction.","volume":"9","author":"Brenta","year":"1999","journal-title":"Thyroid"},{"key":"2023042418250349300_B43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2265.1997.1280950.x","article-title":"Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.","volume":"46","author":"Guo","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023042418250349300_B44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02191961","article-title":"Subclinical hyperthyroidism: physical and mental state of patients.","volume":"241","author":"Schlote","year":"1992","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2023042418250349300_B45","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF01667147","article-title":"Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism.","volume":"68","author":"Bommer","year":"1990","journal-title":"Klin Wochenschr"},{"key":"2023042418250349300_B46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2265.1998.00619.x","article-title":"A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves\u2019 disease.","volume":"49","author":"Watson","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023042418250349300_B47","first-page":"493","article-title":"Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase.","volume":"123","author":"Prentice","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2023042418250349300_B48","first-page":"1028","article-title":"Control of adrenergic overactivity by \u03b2-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.","volume":"78","author":"Biondi","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042418250349300_B49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF03347859","article-title":"Significant reversal of thyrotoxicosis-associated dilated cardiomyopathy with induction of the euthyroid state.","volume":"19","author":"Wilson","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"2023042418250349300_B50","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9149(94)90011-6","article-title":"Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy.","volume":"73","author":"Moruzzi","year":"1994","journal-title":"Am J Cardiol"},{"key":"2023042418250349300_B51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.1994.03510400031027","article-title":"Thyroid hormone use and bone mineral density in elderly women: effect of estrogen.","volume":"271","author":"Schneider","year":"1994","journal-title":"JAMA"},{"key":"2023042418250349300_B52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2265.1994.tb02571.x","article-title":"Bone metabolism during antithyroid drug treatment of endogenous subclinical hyperthyroidism.","volume":"41","author":"Mudde","year":"1994","journal-title":"Clin Endocrinol"},{"key":"2023042418250349300_B53","first-page":"664","article-title":"Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans.","volume":"77","author":"Rosen","year":"1993","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/77\/903\/29\/50041871\/postgradmedj-77-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/77\/903\/29\/50041871\/postgradmedj-77-29.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T18:25:47Z","timestamp":1682360747000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/77\/903\/29\/7039122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":53,"journal-issue":{"issue":"903","published-online":{"date-parts":[[2001,1,1]]},"published-print":{"date-parts":[[2001,1,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pmj.77.903.29","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,1]]},"published":{"date-parts":[[2001,1,1]]}}}